StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Neuroone Medical Technologies's price to sales ratio was 0.7× on Nov 11, 2026, against 3.8× a year earlier. Over the last 5 years it ranged from 0.7× to 274.0×, with a median of 10.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−3.4
2025Dec 31, 20254.2×−3.2
2024Dec 31, 20247.4×−12.0
2023Dec 29, 202319.4×−94.3
2022Dec 30, 2022113.7×−17.1
2021Dec 31, 2021130.8×–

More Neuroone Medical Technologies figures

See a number that looks wrong?